title: Reduced-intensity versus conventional myeloablative conditioning for patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in complete remission.
authors: Satoshi
authors: S
authors: Nishiwaki
authors: Yoshihiro
authors: Y
authors: Inamoto
authors: Masahiro
authors: M
authors: Imamura
authors: Hisashi
authors: H
authors: Tsurumi
authors: Kazuo
authors: K
authors: Hatanaka
authors: Keisei
authors: K
authors: Kawa
authors: Ritsuro
authors: R
authors: Suzuki
authors: Koichi
authors: K
authors: Miyamura
mesh_terms: D000328:Adult; D004305:Dose-Response Relationship, Drug; D006801:Humans; D054438:Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative / Q000401:mortality / Q000473:pathology / Q000534:rehabilitation / Q000628:therapy*; D019653:Myeloablative Agonists / Q000008:administration & dosage* / Q000627:therapeutic use; D012008:Recurrence; D012074:Remission Induction / Q000379:methods; D033581:Stem Cell Transplantation / Q000379:methods; D016019:Survival Analysis; D019172:Transplantation Conditioning / Q000379:methods*; D014184:Transplantation, Homologous
chemical_list: D019653:Myeloablative Agonists